Teraphysics Executes Space Act Agreement
Teraphysics Executes Space Act Agreement
Hopes to Qualify and Certify Operating Characteristics of its Patented “Miniaturized” TWT
Teraphysics, a privately held, Cleveland, Ohio-based R&D company announces that it has executed a non-reimbursable Space Act Agreement with NASA’s Glenn Research Facility in Cleveland.
“The testing of our disruptive technology by NASA is the culmination of 20-plus years of research and development.”
Dr. Gerald Mearini, Teraphysics
Teraphysics entered this agreement for the purpose of performing radio frequency (RF) characterization of its patented, micro fabricated E-band helical traveling wave tube amplifier and to ascertain its suitability for space-to-earth RF telecommunication link. The schedule of work includes:
Certification for use as a communication amplifier for satellite and terrestrial communications
Quantification of performance parameters
Demonstration of terrestrial performance in a stand-alone 1-mile radio link
“This marks an historic milestone achievement in our corporate history. The testing of our disruptive technology by NASA is the culmination of 20-plus years of research and development with investments from the private sector and numerous US Government funded projects," said Dr. Gerald Mearini, Teraphysics Co-Founder and CEO. "We are both honored and humbled to have this incredible collaboration and look forward to working closely with our colleagues at NASA Glenn as we enter this next evolutionary phase in our technology development.”
The agreement allows the company to characterize, certify and qualify its patented “miniaturized” TWT for RF communications that could be incorporated and used in future LEO constellations and existing 5G, 6G and future wireless terrestrial communications. Testing is expected to commence in Q3/2023 with completion of the testing anticipated in Q2, 2025.